MRI, Enhanced CT, and FDG PET/CT in Basal Cell Carcinoma of the Prostate

ABSTRACTPrimary basal cell carcinoma of the prostate is a very rare neoplasm with a good prognosis. A 55-year-old man presented with urinary frequency for 2 months. Serum prostate-specific antigen level was normal. T2-weighted MR images showed an inhomogeneously hyperintense tumor in the prostate. E...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 2014-08, Vol.39 (8), p.721-724
Main Authors: Dong, Aisheng, Zuo, Changjing, Lu, Jianping, Wang, Yang
Format: Article
Language:English
Subjects:
Carcinoma, Basal Cell - diagnosis
Carcinoma, Basal Cell - diagnostic imaging
Fluorodeoxyglucose F18
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Multimodal Imaging
Positron-Emission Tomography
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - diagnostic imaging
Radiopharmaceuticals
Tomography, X-Ray Computed
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACTPrimary basal cell carcinoma of the prostate is a very rare neoplasm with a good prognosis. A 55-year-old man presented with urinary frequency for 2 months. Serum prostate-specific antigen level was normal. T2-weighted MR images showed an inhomogeneously hyperintense tumor in the prostate. Enhanced CT showed heterogeneous enhancement of the tumor. FDG PET/CT showed strong FDG uptake of the tumor with SUVmax of 14.1. Prostate biopsy findings revealed basal cell carcinoma with high proliferation index.
ISSN:0363-9762
1536-0229
DOI:10.1097/RLU.0000000000000280